vs

Side-by-side financial comparison of CROWN CRAFTS INC (CRWS) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

CROWN CRAFTS INC is the larger business by last-quarter revenue ($20.7M vs $14.7M, roughly 1.4× IRIDEX CORP). On growth, CROWN CRAFTS INC posted the faster year-over-year revenue change (-11.3% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs -6.7%).

Crown Crafts is a publicly held American company headquartered in Gonzales, Louisiana. The company designs, markets and distributes infant, toddler and juvenile consumer products. Its stock is traded on the NASDAQ Capital Market under the ticker symbol "CRWS".

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

CRWS vs IRIX — Head-to-Head

Bigger by revenue
CRWS
CRWS
1.4× larger
CRWS
$20.7M
$14.7M
IRIX
Growing faster (revenue YoY)
CRWS
CRWS
+58.5% gap
CRWS
-11.3%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
-6.7%
CRWS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CRWS
CRWS
IRIX
IRIX
Revenue
$20.7M
$14.7M
Net Profit
$1.5M
Gross Margin
23.5%
37.2%
Operating Margin
-0.5%
Net Margin
7.3%
Revenue YoY
-11.3%
-69.7%
Net Profit YoY
69.1%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRWS
CRWS
IRIX
IRIX
Q4 25
$20.7M
$14.7M
Q3 25
$23.7M
$12.5M
Q2 25
$15.5M
$13.6M
Q1 25
$23.2M
$11.9M
Q4 24
$23.4M
$12.7M
Q3 24
$24.5M
$11.6M
Q2 24
$16.2M
$12.6M
Q1 24
$11.8M
Net Profit
CRWS
CRWS
IRIX
IRIX
Q4 25
$1.5M
Q3 25
$1.2M
$-1.6M
Q2 25
$-1.1M
$-994.0K
Q1 25
$-10.8M
$-1.7M
Q4 24
$893.0K
$-834.0K
Q3 24
$860.0K
$-1.9M
Q2 24
$-322.0K
$-2.7M
Q1 24
$-3.5M
Gross Margin
CRWS
CRWS
IRIX
IRIX
Q4 25
23.5%
37.2%
Q3 25
27.7%
32.1%
Q2 25
22.7%
34.5%
Q1 25
18.3%
42.5%
Q4 24
26.1%
44.0%
Q3 24
28.4%
37.3%
Q2 24
24.5%
40.7%
Q1 24
37.9%
Operating Margin
CRWS
CRWS
IRIX
IRIX
Q4 25
-0.5%
Q3 25
7.9%
-11.3%
Q2 25
-7.7%
-6.9%
Q1 25
-60.7%
-1.7%
Q4 24
7.3%
-3.9%
Q3 24
6.2%
-16.1%
Q2 24
-1.8%
-20.9%
Q1 24
-28.0%
Net Margin
CRWS
CRWS
IRIX
IRIX
Q4 25
7.3%
Q3 25
4.9%
-12.6%
Q2 25
-7.1%
-7.3%
Q1 25
-46.4%
-14.2%
Q4 24
3.8%
-6.6%
Q3 24
3.5%
-16.7%
Q2 24
-2.0%
-21.2%
Q1 24
-29.5%
EPS (diluted)
CRWS
CRWS
IRIX
IRIX
Q4 25
Q3 25
$-0.09
Q2 25
$-0.10
$-0.06
Q1 25
$-0.10
Q4 24
$-0.05
Q3 24
$-0.12
Q2 24
$-0.03
$-0.16
Q1 24
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRWS
CRWS
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$2.4M
$6.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$39.2M
Total Assets
$76.1M
$29.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRWS
CRWS
IRIX
IRIX
Q4 25
$2.4M
$6.0M
Q3 25
$810.0K
$5.6M
Q2 25
$227.0K
$6.8M
Q1 25
$521.0K
$7.2M
Q4 24
$1.1M
$2.4M
Q3 24
$2.0M
$3.9M
Q2 24
$1.1M
$4.1M
Q1 24
$5.4M
Total Debt
CRWS
CRWS
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
CRWS
CRWS
IRIX
IRIX
Q4 25
$39.2M
Q3 25
$38.4M
$4.7M
Q2 25
$37.9M
$6.1M
Q1 25
$39.6M
$852.0K
Q4 24
$51.1M
$2.1M
Q3 24
$50.8M
$2.6M
Q2 24
$50.7M
$4.2M
Q1 24
$6.5M
Total Assets
CRWS
CRWS
IRIX
IRIX
Q4 25
$76.1M
$29.2M
Q3 25
$77.5M
$28.4M
Q2 25
$76.0M
$31.6M
Q1 25
$81.2M
$34.2M
Q4 24
$98.7M
$29.1M
Q3 24
$99.3M
$30.2M
Q2 24
$76.4M
$31.2M
Q1 24
$34.1M
Debt / Equity
CRWS
CRWS
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRWS
CRWS
IRIX
IRIX
Operating Cash FlowLast quarter
$2.7M
Free Cash FlowOCF − Capex
$2.3M
FCF MarginFCF / Revenue
11.3%
Capex IntensityCapex / Revenue
1.7%
Cash ConversionOCF / Net Profit
1.78×
TTM Free Cash FlowTrailing 4 quarters
$9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRWS
CRWS
IRIX
IRIX
Q4 25
$2.7M
Q3 25
$-845.0K
$-1.2M
Q2 25
$5.2M
$-397.0K
Q1 25
$2.8M
$-1.1M
Q4 24
$-36.0K
$-1.2M
Q3 24
$-983.0K
$-3.1M
Q2 24
$8.0M
$-1.3M
Q1 24
$-1.6M
Free Cash Flow
CRWS
CRWS
IRIX
IRIX
Q4 25
$2.3M
Q3 25
$-1.0M
$-1.2M
Q2 25
$5.2M
$-410.0K
Q1 25
$2.6M
$-1.2M
Q4 24
$-220.0K
$-1.2M
Q3 24
$-1.2M
$-3.1M
Q2 24
$7.7M
Q1 24
$-1.7M
FCF Margin
CRWS
CRWS
IRIX
IRIX
Q4 25
11.3%
Q3 25
-4.3%
-9.4%
Q2 25
33.4%
-3.0%
Q1 25
11.3%
-9.8%
Q4 24
-0.9%
-9.8%
Q3 24
-4.8%
-26.5%
Q2 24
47.7%
Q1 24
-14.0%
Capex Intensity
CRWS
CRWS
IRIX
IRIX
Q4 25
1.7%
Q3 25
0.7%
0.1%
Q2 25
0.6%
0.1%
Q1 25
0.9%
0.1%
Q4 24
0.8%
0.1%
Q3 24
0.8%
0.0%
Q2 24
1.8%
0.0%
Q1 24
0.0%
Cash Conversion
CRWS
CRWS
IRIX
IRIX
Q4 25
1.78×
Q3 25
-0.73×
Q2 25
Q1 25
Q4 24
-0.04×
Q3 24
-1.14×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons